Pulse Biosciences Operating Income 2016-2024 | PLSE
Pulse Biosciences operating income from 2016 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Pulse Biosciences Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $-56 |
| 2023 | $-44 |
| 2022 | $-58 |
| 2021 | $-63 |
| 2020 | $-50 |
| 2019 | $-48 |
| 2018 | $-38 |
| 2017 | $-26 |
| 2016 | $-10 |
| 2015 | $-4 |
| Pulse Biosciences Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-20 |
| 2024-09-30 | $-14 |
| 2024-06-30 | $-12 |
| 2024-03-31 | $-11 |
| 2023-12-31 | $-13 |
| 2023-09-30 | $-11 |
| 2023-06-30 | $-10 |
| 2023-03-31 | $-10 |
| 2022-12-31 | $-9 |
| 2022-09-30 | $-18 |
| 2022-06-30 | $-14 |
| 2022-03-31 | $-17 |
| 2021-12-31 | $-15 |
| 2021-09-30 | $-14 |
| 2021-06-30 | $-15 |
| 2021-03-31 | $-19 |
| 2020-12-31 | $-14 |
| 2020-09-30 | $-13 |
| 2020-06-30 | $-11 |
| 2020-03-31 | $-12 |
| 2019-12-31 | $-14 |
| 2019-09-30 | $-12 |
| 2019-06-30 | $-12 |
| 2019-03-31 | $-10 |
| 2018-12-31 | $-9 |
| 2018-09-30 | $-11 |
| 2018-06-30 | $-9 |
| 2018-03-31 | $-9 |
| 2017-12-31 | $-9 |
| 2017-09-30 | $-8 |
| 2017-06-30 | $-6 |
| 2017-03-31 | $-3 |
| 2016-12-31 | $-3 |
| 2016-09-30 | $-3 |
| 2016-06-30 | $-2 |
| 2016-03-31 | $-2 |
| 2015-12-31 | $-2 |
| 2015-09-30 | $-1 |
| 2015-06-30 | $-1 |
| 2015-03-31 | $-1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.156B | $0.001B |
| Pulse Biosciences, Inc. is a medical device company. It is engaged in developing a novel and proprietary tissue treatment platform using Nano-Pulse Electro-Signaling. NPES provide effective local tumor control and to initiate an adaptive immune response. The company deploy NPES platform applications which include human oncology, dermatology, aesthetics and other minimally invasive applications. Pulse Biosciences, Inc. is based in Burlingame, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $189.754B | 83.11 |
| Thermo Fisher Scientific (TMO) | United States | $159.887B | 19.34 |
| Alcon (ALC) | Switzerland | $48.486B | 32.23 |
| Edwards Lifesciences (EW) | United States | $44.472B | 29.10 |
| IDEXX Laboratories (IDXX) | United States | $37.951B | 43.61 |
| DexCom (DXCM) | United States | $32.004B | 49.47 |
| IQVIA Holdings (IQV) | United States | $27.061B | 14.97 |
| Mettler-Toledo (MTD) | United States | $22.925B | 27.19 |
| STERIS (STE) | Ireland | $22.088B | 25.26 |
| Waters (WAT) | United States | $20.850B | 29.52 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.568B | 0.00 |
| Hologic (HOLX) | United States | $12.153B | 13.11 |
| Sysmex ADR (SSMXY) | Japan | $11.545B | 0.00 |
| Penumbra (PEN) | United States | $11.463B | 89.97 |
| Globus Medical (GMED) | United States | $9.891B | 22.90 |
| Masimo (MASI) | United States | $8.993B | 37.74 |
| Teleflex (TFX) | United States | $5.586B | 9.22 |
| Glaukos (GKOS) | United States | $5.006B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.385B | 22.97 |
| PROCEPT BioRobotics (PRCT) | United States | $3.077B | 0.00 |
| TransMedics (TMDX) | United States | $3.044B | 89.09 |
| Veracyte (VCYT) | United States | $2.377B | 42.75 |
| Nihon Kohden (NHNKY) | Japan | $2.113B | 11.55 |
| LivaNova (LIVN) | United Kingdom | $2.005B | 12.14 |
| Elekta AB (EKTAY) | Sweden | $1.960B | 17.62 |
| Alphatec Holdings (ATEC) | United States | $1.754B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.431B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.302B | 6.58 |
| OPKO Health (OPK) | United States | $1.098B | 0.00 |
| Artivion (AORT) | United States | $0.996B | 93.32 |
| AxoGen (AXGN) | United States | $0.780B | 0.00 |
| IRadimed (IRMD) | United States | $0.680B | 35.65 |
| Mesa Laboratories (MLAB) | United States | $0.647B | 14.14 |
| RxSight (RXST) | United States | $0.644B | 0.00 |
| SiBone (SIBN) | United States | $0.595B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.565B | 9.10 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.538B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.520B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.513B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.457B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.415B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| NeuroPace (NPCE) | United States | $0.392B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.377B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.347B | 7.36 |
| Pacific Biosciences Of California (PACB) | United States | $0.339B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.333B | 17.82 |
| Neuronetics (STIM) | United States | $0.301B | 0.00 |
| CVRx (CVRX) | United States | $0.207B | 0.00 |
| 908 Devices (MASS) | United States | $0.200B | 0.00 |
| Inogen (INGN) | United States | $0.194B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.183B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.160B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.158B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.135B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.132B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.102B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.083B | 0.00 |
| InspireMD (NSPR) | Israel | $0.083B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 10.82 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.036B | 0.00 | |
| Biosig Technologies (BSGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.014B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.32 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |